In Vivo Effect of a Synthetic Amniotic Fluid on Fetal Lung and Gastrointestinal Tract: A Pre‐Clinical Rodent Model
Prenatal Diagnosis · 2026-04 · 46 (4) · 546-555
DOI: 10.1002/pd.70130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 25.03.2026. Verfasst von Braxton Forde und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Amniotic Fluid, Lung, Gastrointestinal Tract. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: North American Fetal Therapy Network, Brianna Marie Foundation.
Abstract (Originalsprache)
Objective
Amnioinfusions in anhydramnios aim to promote fetal lung development, but currently used fluids (Normal Saline [NS], Lactated Ringer's [LR]) fail to mimic the intrauterine environment and increase reactive oxygen species (ROS). We developed a synthetic amniotic fluid (Amnio‐well, AW) designed to reduce intrauterine ROS. This study evaluated the pulmonary and gastrointestinal effects of 2 formulations of AW compared with those of NS and LR in a pre‐clinical model.
Method
At gestational age E17.5, pregnant rats underwent amniotic fluid replacement with NS, LR, AW, AW plus epidermal growth factor and transforming growth factor‐β (AW++), or sham control. Fetal lungs were harvested at E20.5 for histology, fractional airspace, and blinded pathological evaluation. Surfactant protein (SP‐A, SP‐B, SP‐C) expression and inflammatory gene panels were assessed in lungs and gastrointestinal (GI) tissue.
Results
NS and LR lungs demonstrated edema, macrophage infiltration, and reduced airspace ( p < 0.001). AW improved SP‐B and SP‐C relative to control, whereas AW++ suppressed SP‐B and SP‐C ( p < 0.05). Lung gene profiling showed NS/LR induced alterations in histamines, annexins, and immune recruitment, while AW closely resembled control. GI histology was similar across groups, though NS/LR altered TNF, prostaglandin, and adhesion pathways ( p < 0.05).
Conclusion
AW reduced lung inflammation and enhanced surfactant expression compared with NS or LR, with minimal GI effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Center for Fetal and Placental Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatric Surgery, General and Thoracic, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Radiation Oncology, University of Cininnati College of Medicine, Cincinnati, Ohio, USA.
- Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Braxton Forde
Förderung
- North American Fetal Therapy Network
- Brianna Marie Foundation
Zitieren
APA
Forde, B., Finoti, S., Oria, M., & Peiro, J. L. (2026). In Vivo Effect of a Synthetic Amniotic Fluid on Fetal Lung and Gastrointestinal Tract: A Pre‐Clinical Rodent Model. Prenatal Diagnosis, 46(4), 546-555. https://doi.org/10.1002/pd.70130
Vancouver
Forde B, Finoti S, Oria M, Peiro JL. In Vivo Effect of a Synthetic Amniotic Fluid on Fetal Lung and Gastrointestinal Tract: A Pre‐Clinical Rodent Model. Prenatal Diagnosis. 2026;46(4):546-555. doi:10.1002/pd.70130
BibTeX
@article{Forde2026,
author = {Forde, Braxton and Finoti, Stephanie and Oria, Marc and Peiro, Jose L},
title = {In Vivo Effect of a Synthetic Amniotic Fluid on Fetal Lung and Gastrointestinal Tract: A Pre‐Clinical Rodent Model},
journal = {Prenatal Diagnosis},
year = {2026},
volume = {46},
number = {4},
pages = {546--555},
doi = {10.1002/pd.70130}
}
EUVIMED